Business Context and Reporting Period
This Form 8-K filing by Leidos Holdings, Inc. (Leidos) reports a material definitive agreement entered into on April 14, 2026. The filing date is April 15, 2026. The document details the formation of a new joint venture (JV) combining Leidos' Security Enterprise Solutions (SES) and Industrial Automation (IA) businesses with Analogic Corporation, a portfolio company of Altaris, LLC.
Key Financial Metrics and Transaction Structure
The filing does not provide specific revenue, profit, cash flow, margin, debt, or liquidity figures for Leidos or the businesses involved. Instead, it outlines the equity structure of the proposed joint venture:
- Leidos Equity Stake: Leidos Inc. will contribute subsidiaries holding the SES/IA Business assets in exchange for 41.5% of the JV's equity securities.
- Altaris/Analogic Equity Stake: Affiliates of Altaris (AHP Entities) will contribute a portion of Analogic Holding Company equity in exchange for 58.5% of the JV's equity securities.
- Debt Financing: The JV is expected to obtain new debt financing to purchase the remaining equity interests of Analogic Holding from the AHP Entities.
- Valuation Adjustment: The agreement includes a customary post-closing contribution value adjustment.
Material Changes and Transaction Timeline
The primary material change is the strategic restructuring of Leidos' SES/IA Business. Key timeline and condition details include:
- Expected Closing: The transactions are expected to close in the second half of 2026.
- Restructuring: Leidos must effectuate a pre-closing restructuring of the SES/IA Business prior to contribution.
- Termination Rights: The agreement may be terminated if the transactions are not consummated by the six-month anniversary of the agreement date (October 14, 2026), subject to an automatic three-month extension.
Guidance, Risks, and Contingencies
The filing contains no specific financial guidance or management commentary regarding future earnings, but it highlights significant risks and contingencies:
- Closing Conditions: Consummation is subject to regulatory approvals (including HSR Act waiting periods), absence of prohibitive laws, accuracy of representations, and the JV securing debt financing.
- Operational Risks: Risks include the ability to integrate the businesses, U.S. government budget constraints, geopolitical events, inflation, and cybersecurity threats.
- Restrictive Covenants: Leidos is subject to non-competition and non-solicitation provisions post-closing.
- Insurance: Leidos has bound a representations and warranties insurance policy to cover losses from breaches by the AHP Entities.
Investor Verification Checklist
- Verify the status of regulatory approvals, specifically the expiration of the Hart-Scott-Rodino waiting period.
- Confirm the successful execution of the pre-closing restructuring of the SES/IA Business.
- Monitor the JV's ability to secure the necessary debt financing to purchase the remaining Analogic equity.
- Review the full text of the Contribution Agreement (Exhibit 2.1) for specific materiality standards and termination clauses.
- Assess the impact of the 41.5% equity stake on Leidos' future consolidated financial reporting and potential divestiture of the SES/IA segment.